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Abstract
Background:  Collision  tumours  are  extremely  rare.  They  are  deﬁned  by  the  presence  of  two
tumours  of  different  histological  origin  in  the  same  organ.
Clinical  case: A  71-year-old  female  with  history  of  a  carcinoid  tumour  removed  20  years  ago
without any  recurrence.  The  patient  was  admitted  with  intestinal  occlusion  symptoms  secondary
to a  right  ﬂank  abdominal  tumour.  An  exploratory  laparotomy  was  performed,  removing  the
tumour and  applying  optimal  debulking.
The histopathological  study  reported  bilateral  ovary  adenocarcinoma,  as  well  as  metastatic
collision tumour  of  two  histological  types:  well  differentiated  adenocarcinoma  and  a  mixed
malignant  mesodermic  Mullerian  tumour.
The patient  was  treated  with  adjuvant  chemotherapy  with  poor  results  (death  in  24  months).
Conclusions:  The  presence  of  collision  tumours  is  extremely  rare.  There  are  no  statistics  or
speciﬁc treatment  reported.  Diagnosis  is  made  with  histopathology.  At  the  moment,  no  similar
cases have  been  reported.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This
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Tumor  metastásico  de  colisión.  Informe  de  un  caso
Resumen
Antecedentes:  Los  tumores  de  colisión  son  raros,  se  deﬁnen  como  la  presencia  de  2  tumores  de
diferente estirpe  histológica  en  el  mismo  órgano  o  sitio.
Caso clínico:  Se  presenta  el  caso  de  una  paciente  femenina  de  71  an˜os,  con  antecedente  de
tumor carcinoide  resecado  hace  20  an˜os,  sin  recidiva.  La  paciente  presenta  cuadro  de  oclusión
intestinal secundario  a  tumor  en  ﬂanco  derecho  del  abdomen.  Se  le  realiza  laparotomía  explo-
radora con  resección  del  tumor,  y  citorreducción  óptima.  En  el  estudio  histopatológico  se
encuentra adenocarcinoma  de  ovario  bilateral,  así  como  tumor  de  colisión  en  metástasis,  el
cual presenta  2  estirpes  histológicas:  adenocarcinoma  bien  diferenciado  y  tumor  mixto  maligno
mülleriano  mesodérmico.  La  paciente  es  enviada  para  quimioterapia  adyuvante,  presentando
mala evolución.  Murió  a  los  24  meses.
Conclusiones:  La  presencia  de  tumores  de  colisión  es  extremadamente  rara,  en  la  literatura  no
hay estadísticas  ni  tratamiento  especíﬁco.  Su  diagnóstico  es  histopatológico.  No  se  ha  reportado
ningún caso  similar  en  la  literatura  médica.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Collision  tumours  are  highly  rare  neoplasias;  there  are  few
series  and  case  reports  on  them  in  the  English  literature.
The  presence  of  several  primary  neoplasias  in  the  same  indi-
vidual  is  a  frequent  occurrence;  they  can  be  synchronous
(within  a  6-month  interval)  or  metachronous  (within  an
interval  longer  than  6  months).  However,  the  presence  of
two  histological  lineages  in  the  same  organ  or  place  is
called  a  collision  tumour.  Histologically,  both  populations
collide  without  there  being  transition  areas  between  them.
They  have  been  described  as  occurring  in  several  places:
the  cardia,  cervix,  bladder,  liver,  lung,  thyroids  and  bil-
iary  ducts.  Most  of  them  are  carcinomas  and  sarcomas
collisions  or  lymphomas  collisions,  and  more  infrequently,
carcinomas  collisions.1 There  are  several  theories,  such  as
the  simultaneous  proliferation  of  two  different  cell  lines,
a  common  origin  from  a  pluripotent  precursor  cell  that
would  differentiate  into  two  components,  or  the  casual
development  of  two  non-related  tumours.  Genetic  predis-
position,  old  age,  exposure  to  environmental  carcinogens,
previous  treatments  with  radiotherapy  or  chemotherapy
and  immunosuppression,  among  others,  are  all  factors  that
increase  the  risk  of  developing  these  tumours.
The  purpose  of  this  study  is  to  show  the  ﬁrst  case  of  a
collision  tumour  in  a  metastasis  in  Mexico,  and  possibly  the
ﬁrst  case  report  in  the  English  language  medical  literature.
Clinical case
The  case  is  a  71-year-old  patient  who  has  a  history  of  intesti-
nal  surgery  due  to  a  carcinoid  tumour  in  her  small  intestine
more  than  20  years  ago;  she  denies  having  additional  medi-
cal  history  of  relevance.
She  was  admitted  in  February  2012,  with  symptoms
of  intermittent  partial  bowel  obstruction,  with  signiﬁcant
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fbdominal  bloating,  constipation,  nausea  and  vomiting,
nd  volume  augmentation  in  right  ﬂank,  non-mobile.  An
bdominal  ultrasound  was  performed,  which  only  showed  an
nechoic  lesion  in  the  left  lobe  of  her  liver.  The  abdominal
omputerised  axial  tomography  showed  the  presence  of  free
uid,  a  hepatic  cyst  that  had  already  been  detected  by  the
onography,  and  a  tumour  that  compressed  the  colon  in  her
ight  ﬂank;  all  these  data  are  an  indication  of  carcinomatosis
Fig.  1).  Laboratory  data  were  within  normal  ranges.
The  patient  did  not  show  any  improvement  from  the
bstruction  symptoms  despite  medical  treatment,  so  an
xploratory  laparotomy  was  performed,  through  which  3  l
erohaematic  ascites,  omental,  mesentery  and  pelvic  vis-
era  implantations  were  found,  with  no  evidence  of  primary;
 12  cm  ×  8  cm  tumour  was  seen  in  the  right  parietocolic  gut-
er  with  encephaloid  aspect,  papillary,  with  good  cleavage
lane,  which  could  be  removed.  Cytoreductive  surgery  was
erformed,  which  included  Piver  1  total  hysterectomy  and
 bilateral  salpingo-oophorectomy  with  optimum  removal
R0).
Patient  was  taken  to  the  surgical  inpatient  unit;  she
howed  good  progress.  She  was  discharged  in  72  h,  with
dequately  tolerated  oral  route.  She  was  sent  to  Medical
ncology  for  adjuvancy  in  March,  2012.  Treatment  with
arboplatin  and  paclitaxel  was  initiated.  The  patient  was
symptomatic  at  her  one-year  follow-up.  However,  disease
ecurrence  occurred  at  month  18,  with  ascites,  abdominal
ain,  weight  loss  and  symptoms  of  partial  bowel  obstruc-
ion.  Patient  decided  not  to  continue  with  any  treatment
nd  died  24  months  after  the  diagnosis.
Histopathology.  There  is  a  neoplastic  lesion  that  cor-
esponds  to  a  well-differentiated  adenocarcinoma  on  the
urface  of  both  ovaries.  It  forms  a  solid  nodule  in  the  right
vary  and  in  the  left  ovary,  over  its  serosa,  and  there  are
any  Psammoma  bodies.  There  is  metastasis  in  the  omen-
al  and  in  the  abdominal  wall,  in  which  there  is  a  lesion
ormed  by  papillary  structures  of  very  variable  size  with  two
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Figure  1  Abdominal  tomography  that  shows  ascites  (thin  arrow),  as  well  as  a  tumour  in  the  right  ﬂank,  that  compresses  the  right
colon (thick  arrow),  these  data  are  an  indication  of  carcinomatosis  (arrow  head).
Figure  2  Immunohistochemistry.  The  use  of  this  technique  is  shown  in  the  ovarian  tumour  (upper  image),  as  well  as  in  the
a
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denocarcinoma  area  of  the  metastasis  (lower  right)  with  negativ
arcomatous area  of  the  metastasis.e  receptors,  and  the  positive  receptors  to  oestrogens  in  the
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types  of  differentiation;  one  of  them  is  epithelial  and  covers
the  surface  of  the  papillary  areas,  the  epithelium  is  strat-
iﬁed  in  many  places  and  it  has  cells  with  hyperchromatic
and  somewhat  pleomorphic  nuclei  with  frequent  mitotic  ﬁg-
ures  and  non-vacuolated  eosinophilic  cytoplasm.  The  second
component  corresponds  to  a  sarcomatosis,  with  a  compact
arrangement  of  cells,  scarce  cytoplasm  with  ill-deﬁned  bor-
ders  and  occasionally  with  uninucleate  or  multinucleate
giant  cells.  There  are  areas  of  desmoplastic  ﬁbrous  stroma
and  of  aponeurotic  tissue  from  the  abdominal  wall.
The  immunohistochemistry  analysis  shows  p53  and  WT1
markers  that  are  positive  in  both  components;  p16  is  only
positive  in  the  sarcomatous  component.  The  endometrial
origin  rests  on  the  CD10,  CA-125  and  oestrogen  receptor
positivity.  The  sarcomatous  component  is  desmin  and  S-100
positive,  and  WT1,  p16  and  CD10  negative.2,3 Oestrogen
receptors  in  the  well-differentiated  adenocarcinoma  part
were  negative,  and  in  the  malignant  mixed  mesodermal
(müllerian)  tumour,  that  were  positive  (Fig.  2).  The  ovaries
presented  a  well-differentiated  adenocarcinoma.We  came  to  a  diagnosis  of  collision  tumour  in  the
abdominal  wall  metastasis,  which  was  formed  by  a  well-
differentiated  adenocarcinoma  component  and  a  malignant
mixed  mesodermal  (müllerian)  tumour  component.
a
c
i
s
Table  1  Reported  collision  tumours.
Author  Age  Gender  Location  
Peng  and  Schwarz4 52  M  Duodenum  
Jimenez Hernandez  et  al.5 33  F  Skin  
Martinez Mun˜oz  et  al.6 65  F  Skin  
Quin˜ones Venegas  et  al.7 83  F  Skin  
Quin˜ones Venegas  et  al.7 55  M  Skin  
Quin˜ones Venegas  et  al.7 37  F  Skin  
Allen et  al.8 63  F  Ovarian  
Jang et  al.9 70  F  Uterus  
Brahmania  et  al.10 64  F  Colon  
Ferrando Marco  et  al.11 64  M  Duodenus-head  of
pancreas
Williams et  al.12 58  M  Ampulla  of  Vater  
Varikatt et  al.13 37  F  Ampulla  of  Vater  
Hirono et  al.14 75  M  Ampulla  of
Vater-common  bile
duct
Patwardhan  and  Gadgil15 55  F  Uterus  
Lifschitz-Mercer  et  al.16 69  F  Uterus  
Sreenan and  Hart17 67  F  Uterus  
Sreenan and  Hart17 72  F  Uterus  
Gaertner et  al.18 49  F  Uterus  
Lam et  al.19 85  F  Uterus  
Lam et  al.19 47  F  Uterus  
Takahashi and  Inoue20 68  F  Uterus  
Shaco et  al.21 79  F  Uterus  
This study  71  F  Peritoneal  metasta
F: female; M: male.241
iscussion
he  physical  examination,  the  ﬁndings  in  imaging  and
esearch  studies  do  not  conﬁrm  the  existence  of  colli-
ion  tumours,  the  latest  being  histopathological  incidents.4
here  have  been  few  reports  about  collision  tumours  in
exico,  with  only  some  skin  cases.5--7
The  combination  of  a  carcinoma  and  a  mixed  mesodermal
umour  is  infrequent.8 Until  now,  there  has  been  no  report
n  medical  literature  of  a  case  similar  to  the  one  presented.
ost  of  the  collision  tumours  are  described  under  gynaeco-
ogical  disorders.  Table  1  shows  some  collision  tumours  with
heir  histological  location  and  lineage.
The  combination  of  tumours  in  one  organ  or  place  can
e  divided  into  two  clinical-pathological  groups:  collision
umour  or  compound  tumour.  In  the  ﬁrst  one,  the  histo-
ogically  different  tissues  juxtapose  with  healthy  stroma
etween  them.  In  the  compound  tumour,  the  different  com-
onents  intermingle  to  form  one  tumour  mass.9
Some  theories  about  collision  tumours  regard  them  as
 proliferation  of  two  different  cell  lines,  or  as  having  a
ommon  origin  in  a  totipotential  cell,  which  differentiates
nto  two  different  cell  lines.10 A  third  theory  involves  the
arcomatous  conversion  of  an  epithelial  tumour.  Lastly,  it
Type  of  collision
Adenocarcinoma  +  neuroendocrine  carcinoma
Solid  basal  cell  carcinoma  +  melanocytic  nevus
Keratoacanthoma  +  seborrheic  keratitis
Pigmented  basal  cell  carcinoma  +  seborrheic  keratosis
Pigmented  basal  cell  carcinoma  +  seborrheic  keratosis
Benign  melanocytic  lesion  +  seborrheic  keratosis
Epithelial  serous  adenoﬁbroma  +  sarcoma  with
rhabdomyoblastic  differentiation
Papillary  serous  carcinoma  +  endometrioid
carcinoma  +  mixed  müllerian  tumour
Granulosa  tumour  +  adenocarcinoma
Duodenal  carcinoid  +  adenocarcinoma
Carcinoid  tumour  +  adenocarcinoma
Somatostatinoma  +  neuroﬁbroma
Adenocarcinoma  +  cholangiocarcinoma
Adenocarcinoma  +  leiomyosarcoma
Well-differentiated  adenocarcinoma  +  high-grade
stromal  sarcoma
Endometrial  adenocarcinoma  +  homologous  sarcoma
Serous  carcinoma  +  heterologous  sarcoma
Endometrioid  adenocarcinoma  +  rhabdomyosarcoma
Endometrioid  adenocarcinoma  +  high-grade
endometrial  sarcoma
Endometrioid  adenocarcinoma  +  high-grade
endometrial  sarcoma
Hepatoid  carcinoma  +  carcinosarcoma
Papillary  serous  carcinoma  +  small-cell  carcinoma
sis  Adenocarcinoma  +  mixed  müllerian  tumour
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242  
s  important  to  differentiate  it  from  a  tumour  that  metasta-
ises  in  another  one.  Mixed  müllerian  tumours  are  aggressive
eoplasias;  extragonadal  presence  is  infrequent.  In  a  case
resentation,  Kurshumliu  et  al.3 refer  to  only  30  published
ases  in  medical  literature,  the  majority  of  which  involved
ostmenopausal  women.  A  theory  proposed  by  the  same
uthors  is  that  the  origin  is  in  an  endometriotic  area.
The  origin  of  this  tumour  can  probably  be  explained
s  an  ovarian  primary  tumour  metastasis  (adenocarcinoma
omponent)  and  the  sarcomatous  degeneration  of  some
ndometriotic  area  in  the  wall;  both  tumours  collided  in  the
ame  neoplasia.
In  general,  mixed  tumours  have  a  bad  prognosis  and  a
ostoperative  survival  of  14  months,  although  in  our  case
he  survival  was  of  24  months  (12  months  free  of  tumour).
Treatment  for  these  tumours  is  performed  by  implemen-
ing  a  combination  of  therapies,  treating  each  tumour  as  if
t  were  the  only  one.  This  case  was  treated  with  surgery  to
olve  the  obstruction  symptoms,  and  then  it  was  decided  to
nitiate  chemotherapy  with  carboplatin  and  paclitaxel  (since
t  is  a  useful  method  in  epithelial  ovarian  tumours,  as  well
s  in  uterine  sarcomas).
onclusion
ollision  tumours  are  infrequent  neoplasias;  there  are  few
eports  about  them  in  medical  literature.  Their  prognosis
s  unknown,  since  there  are  no  previous  similar  cases.  It  is
ossible  that  long-term  survival  is  similar  to  that  for  mixed
eritoneal  müllerian  tumours.
The  treatment  adapted  to  this  case  was  surgery  with
ptimal  cytoreduction,  as  well  as  adjuvancy.
onﬂict of interests
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